Molecular Neurobiology

, Volume 55, Issue 5, pp 3875–3888 | Cite as

Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Activation Balance Astrocyte Polarization into a Proinflammatory Phenotype

  • Gerardo Rosciszewski
  • Vanesa Cadena
  • Veronica Murta
  • Jeronimo Lukin
  • Alejandro Villarreal
  • Thierry Roger
  • Alberto Javier Ramos
Article

Abstract

Astrocytes react to brain injury with a generic response known as reactive gliosis, which involves activation of multiple intracellular pathways including several that may be beneficial for neuronal survival. However, by unknown mechanisms, reactive astrocytes can polarize into a proinflammatory phenotype that induces neurodegeneration. In order to study reactive gliosis and astroglial polarization into a proinflammatory phenotype, we used cortical devascularization-induced brain ischemia in Wistar rats and primary astroglial cell cultures exposed to oxygen-glucose deprivation (OGD). We analyzed the profile of TLR4 expression and the consequences of its activation by gain- and loss-of-function studies, and the effects produced by the activation of triggering receptor expressed on myeloid cells-2 (TREM-2), a negative regulator of TLR4 signaling. Both OGD exposure on primary astroglial cell cultures and cortical devascularization brain ischemia in rats induced TLR4 expression in astrocytes. In vivo, astroglial TLR4 expression was specifically observed in the ischemic penumbra surrounding necrotic core. Functional studies showed that OGD increased the astroglial response to the TLR4 agonist lipopolysaccharide (LPS), and conversely, TLR4 knockout primary astrocytes had impaired nuclear factor kappa-B (NF-κB) activation when exposed to LPS. In gain-of-function studies, plasmid-mediated TLR4 over-expression exacerbated astroglial response to LPS as shown by sustained NF-κB activation and increased expression of proinflammatory cytokines IL-1β and TNFα. TREM-2 expression, although present in naïve primary astrocytes, was induced by OGD, LPS, or high-mobility group box 1 protein (HMGB-1) exposure. TREM-2 activation by antibody cross-linking or the overexpression of TREM-2 intracellular adaptor, DAP12, partially suppressed LPS-induced NF-κB activation in purified astrocytic cultures. In vivo, TREM-2 expression was observed in macrophages and astrocytes located in the ischemic penumbra. While TREM-2+ macrophages were abundant at 3 days post-lesion (DPL) in the ischemic core, TREM-2+ astrocytes persisted in the penumbra until 14DPL. This study demonstrates that TLR4 expression increases astroglial sensitivity to ligands facilitating astrocyte conversion towards a proinflammatory phenotype, and that astroglial TREM-2 modulates this response reducing the downstream NF-κB activation. Therefore, the availability of TLR4 and TREM-2 ligands in the ischemic environment may control proinflammatory astroglial conversion to the neurodegenerative phenotype.

Keywords

Reactive gliosis Inflammation Ischemia Astrocyte Microglia TLR4 TREM-2 NF-κB 

Notes

Acknowledgements

GR and VC are doctoral fellows from CONICET. AJR and VM are researchers from CONICET (Argentina). We thank Dr. Marina Snitcofsky, Biot. Andrea Pecile, and Manuel Ponce for the animal care and Dr. Carla Bonavita for the correction of the manuscript.

Author’s Contributions

GR, AV, and AJR designed the experiments; GR, VC, VM, JL, and AV did the experimental work and analysis; GR, VC, VM, and AJR analyzed and interpreted the data; TR provided the proprietary essential reagents developed by his group; AJR wrote the article; and AJR, AV, VM, VC, JL, and TR revised the manuscript.

Compliance with Ethical Standards

Availability of Data and Materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Competing Interests

The authors declare that they have no competing interests.

Ethics Approval and Consent to Participate

The animal care for this experimental protocol was in accordance with the NIH guidelines for the Care and Use of Laboratory Animals, the principles presented in the Guidelines for the Use of Animals in Neuroscience Research by the Society for Neuroscience and the ARRIVE guidelines, and it was approved by the CICUAL committee of the School of Medicine, University of Buenos Aires.

Funding

Supported by grants CONICET PIP, ANPCYT PICT2012–1424, and UBACYT assigned to AJR and by grants from the Swiss National Science Foundation (SNF 145014 and 149511) to TR. Funding agencies provided the research grants that supported all materials, reagents, and services required to perform the experiments included in this manuscript.

Supplementary material

12035_2017_618_MOESM2_ESM.docx (17 kb)
Supplementary Table I (DOCX 16 kb)
12035_2017_618_Fig7_ESM.gif (233 kb)
Supplementary Figure 1 Specificity of anti-TLR4 antibodies. Images of anti-TLR4 staining in the ischemic core infiltrated with blood-borne leukocytes in wild type and TLR4 −/− mice and nuclear counterstaining with DAPI. Note the absence of TLR4 immunostaining in TLR4 −/− mice. Bar = 60 μm. (GIF 232 kb)
12035_2017_618_MOESM1_ESM.tif (3 mb)
High resolution image (TIFF 3095 kb)

References

  1. 1.
    Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35CrossRefPubMedGoogle Scholar
  2. 2.
    Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA (2012) Genomic analysis of reactive astrogliosis. J Neurosci 32:6391–6410CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81:229–248CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Villarreal A, Seoane R, González Torres A, Rosciszewski G, Angelo MF, Rossi A, Barker PA, Ramos AJ (2014) S100B protein activates a RAGE-dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis. J Neurochem 131:190–205CrossRefPubMedGoogle Scholar
  5. 5.
    Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia 59:242–255CrossRefPubMedGoogle Scholar
  6. 6.
    Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia 61:349–360CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Kong H, Yin F, He F, Omran A, Li L, Wu T, Wang Y, Peng J (2015) The effect of miR-132, miR-146a, and miR-155 on MRP8/TLR4-induced astrocyte-related inflammation. J Mol Neurosci 57:28–37CrossRefPubMedGoogle Scholar
  8. 8.
    Serramía MJ, Muñoz-Fernández MÁ, Álvarez S (2015) HIV-1 increases TLR responses in human primary astrocytes. Sci Rep 5:17887CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Anderson MA, Burda JE, Ren Y, Ao Y, O’Shea TM, Kawaguchi R, Coppola G, Khakh BS et al (2016) Astrocyte scar formation aids central nervous system axon regeneration. Nature 532:195–200CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Marinelli C, Di Liddo R, Facci L, Bertalot T, Conconi MT, Zusso M, Skaper SD, Giusti P (2015) Ligand engagement of toll-like receptors regulates their expression in cortical microglia and astrocytes. J Neuroinflammation 12:244CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Holm TH, Draeby D, Owens T (2012) Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia 60:630–638CrossRefPubMedGoogle Scholar
  12. 12.
    Herrera DG, Robertson HA (1989) Unilateral induction of c-fos protein in cortex following cortical devascularization. Brain Res 503:205–213CrossRefPubMedGoogle Scholar
  13. 13.
    Villarreal A, Aviles Reyes RX, Angelo MF, Reines AG, Ramos AJ (2011) S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. J Neurochem 117:321–332CrossRefPubMedGoogle Scholar
  14. 14.
    Villarreal A, Rosciszewski G, Murta V, Cadena V, Usach V, Dodes-Traian MM, Setton-Avruj P, Barbeito LH et al (2016) Isolation and characterization of ischemia-derived astrocytes (IDAs) with ability to transactivate quiescent astrocytes. Front Cell Neurosci 10:139CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lee W, Parpura V (2012) Dissociated cell culture for testing effects of carbon nanotubes on neuronal growth. Methods Mol Biol 846:261–276CrossRefPubMedGoogle Scholar
  16. 16.
    Angelo MF, Aguirre A, Avilés Reyes RX, Villarreal A, Lukin J, Melendez M, Vanasco V, Barker P et al (2014) The proinflammatory RAGE/NF-κB pathway is involved in neuronal damage and reactive gliosis in a model of sleep apnea by intermittent hypoxia. PLoS One 9:e107901CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Goslin K, Schreyer DJ, Skene JH, Banker G (1988) Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature 336(6200):672–674CrossRefPubMedGoogle Scholar
  18. 18.
    Roger T, David J, Glauser MP, Calandra T (2001) MIF regulates innate immune responses through modulation of toll-like receptor 4. Nature 414:920–924CrossRefPubMedGoogle Scholar
  19. 19.
    Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage. J Biol Chem 288:33027–33036CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Murta V, Farías MI, Pitossi FJ, Ferrari CC (2015) Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood-brain barrier integrity. J Neuroimmunol 278:30–43CrossRefPubMedGoogle Scholar
  21. 21.
    Avilés-Reyes RX, Angelo MF, Villarreal A, Rios H, Lazarowski A, Ramos AJ (2001) Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea. J Neurochem 112:854–869CrossRefGoogle Scholar
  22. 22.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  23. 23.
    Ramos A, Ho WC, Forte S, Dickson K, Boutilier J, Favell K, Barker PA (2007) Hypo-osmolar stress induces p75NTR expression by activating Sp1-dependent transcription. J Neurosci 27:1498–1506CrossRefPubMedGoogle Scholar
  24. 24.
    Nakamura K, Watakabe A, Hioki H, Fujiyama F, Tanaka Y, Yamamori T, Kaneko T (2007) Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient. Eur J Neurosci 26:3054–3067CrossRefPubMedGoogle Scholar
  25. 25.
    Burgos M, Pastor MD, González JC, Martinez-Galan JR, Vaquero CF, Fradejas N, Benavides A, Hernández-Guijo JM et al (2007) PKCepsilon upregulates voltage-dependent calcium channels in cultured astrocytes. Glia 55:1437–1448CrossRefPubMedGoogle Scholar
  26. 26.
    Scarisbrick IA, Radulovic M, Burda JE, Larson N, Blaber SI, Giannini C, Blaber M, Vandell AG (2012) Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biol Chem 393:355–367CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Savva A, Roger T (2013) Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol 4:387CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G et al (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 28:12023–12031CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    van Beijnum JR, Buurman WA, Griffioen AW (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11:91–99CrossRefPubMedGoogle Scholar
  30. 30.
    Lee JY, Lee JD, Phipps S, Noakes PG, Woodruff TM (2015) Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 12:90CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH, Moskowitz MA, Sims JR (2010) High-mobility group box 1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia. Stroke 41:2077–2082CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Nakano Y, Furube E, Morita S, Wanaka A, Nakashima T, Miyata S (2015) Astrocytic TLR4 expression and LPS-induced nuclear translocation of STAT3 in the sensory circumventricular organs of adult mouse brain. J Neuroimmunol 278:144–158CrossRefPubMedGoogle Scholar
  33. 33.
    Mishra BB, Mishra PK, Teale JM (2006) Expression and distribution of toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181:46–56CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Zhang Z, Zhang ZY, Wu Y, Schluesener HJ (2012) Immunolocalization of toll-like receptors 2 and 4 as well as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury. Neuroimmunomodulation 19:10–19CrossRefPubMedGoogle Scholar
  35. 35.
    Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115:1599–1608CrossRefPubMedGoogle Scholar
  36. 36.
    De Paola M, Mariani A, Bigini P, Peviani M, Ferrara G, Molteni M, Gemma S, Veglianese P et al (2012) Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration. Mol Med 18:971–981PubMedPubMedCentralGoogle Scholar
  37. 37.
    Ramos AJ (2016) Astroglial heterogeneity: merely a neurobiological question? Or an opportunity for neuroprotection and regeneration after brain injury? Neural Regen Res 11:1739–1741CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Barbierato M, Facci L, Argentini C, Marinelli C, Skaper SD, Giusti P (2013) Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype. CNS Neurol Disord Drug Targets 12:608–618CrossRefPubMedGoogle Scholar
  39. 39.
    Facci L, Barbierato M, Marinelli C, Argentini C, Skaper SD, Giusti P (2014) Toll-like receptors 2, −3 and −4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1β release. Sci Rep 4:6824CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010) Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30:8285–8295CrossRefPubMedGoogle Scholar
  41. 41.
    Pelham CJ, Agrawal DK (2014) Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol 10:243–256CrossRefPubMedGoogle Scholar
  42. 42.
    Sugimoto K, Nishioka R, Ikeda A, Mise A, Takahashi H, Yano H, Kumon Y, Ohnishi T et al (2014) Activated microglia in a rat stroke model express NG2 proteoglycan in peri-infarct tissue through the involvement of TGF-β1. Glia 62:185–198CrossRefPubMedGoogle Scholar
  43. 43.
    Hoyos HC, Rinaldi M, Mendez-Huergo SP, Marder M, Rabinovich GA, Pasquini JM, Pasquini LA (2014) Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination. Neurobiol Dis 62:441–455CrossRefPubMedGoogle Scholar
  44. 44.
    Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177:3520–3524CrossRefPubMedGoogle Scholar
  45. 45.
    Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647–657CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 177:2051–2055CrossRefPubMedGoogle Scholar
  47. 47.
    Albertsson AM, Bi D, Duan L, Zhang X, Leavenworth JW, Qiao L, Zhu C, Cardell S et al (2014) The immune response after hypoxia-ischemia in a mouse model of preterm brain injury. J Neuroinflammation 11:153CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Heldmann U, Mine Y, Kokaia Z, Ekdahl CT, Lindvall O (2011) Selective depletion of mac-1-expressing microglia in rat subventricular zone does not alter neurogenic response early after stroke. Exp Neurol 229:391–398CrossRefPubMedGoogle Scholar
  49. 49.
    Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109:1144–1156CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37:1290–1301CrossRefPubMedGoogle Scholar
  51. 51.
    Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Universidad de Buenos Aires, Facultad de Medicina, Departamento de Histología, Embriología, Biología Celular y GenéticaBuenos AiresArgentina
  2. 2.Laboratorio de Neuropatología Molecular, Instituto de Biología Celular y Neurociencia “Prof. E. De Robertis” Facultad de MedicinaUniversidad de Buenos AiresCiudad de Buenos AiresArgentina
  3. 3.Department of Molecular Embryology, Institute for Anatomy and Cell BiologyUniversity of FreiburgFreiburgGermany
  4. 4.Infectious Diseases Service, Department of MedicineLausanne University HospitalEpalingesSwitzerland

Personalised recommendations